Syner-G BioPharma Group
↗Framingham, Massachusetts, USA
Syner-G BioPharma Group is a premier provider of comprehensive services in product development, regulatory strategy, medical writing, and quality/cGxP compliance for the life sciences industry. The company utilizes its proprietary 'CMC 360™' model to provide integrated scientific, regulatory, and technical consulting across the entire drug development lifecycle, from early-stage development through commercialization.
In 2024, the company underwent a strategic combination with Sequoia Biotech Consulting, creating a unified, larger organization with a global reach of over 400 professionals across North America, Europe, and India. The company is backed by private equity firm Riverside Partners and focuses on supporting small molecule, biologics, cell and gene therapy, and medical device innovators.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:2007
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:Riverside Partners
PIPELINE
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, Medical devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:RMC Pharmaceutical Solutions
Key Partnerships:Riverside Partners (Private Equity Owner)
COMPETITION
Position:Leader
Competitors:Ironwood Pharmaceuticals, Cubist Pharmaceuticals, Jupiter Life Science Consulting
LEADERSHIP
Key Executives:
Ron Kraus - CEO
Scott Rudge - Founder
Scientific Founders:Scott Rudge
LINKS
Website:synergbiopharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Syner-G BioPharma Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Syner-G BioPharma Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.